Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald J Tindall

Showing results (11-20 of 102) with videos related to

Pageof 11
Sort By:
The Journal of Biological Chemistry|July 28, 2006
Ligand-independent androgen receptor activity is activation function-2-independent and resistant to antiandrogens in androgen refractory prostate cancer cellsScott M Dehm, Donald J Tindall
Expert Review of Endocrinology & Metabolism|March 16, 2010
Androgen receptor abnormalities in castration-recurrent prostate cancerLucas P Nacusi, Donald J Tindall
Endocrine Reviews|October 18, 2007
Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complexHannelore V Heemers, Donald J Tindall
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2011
Androgen receptor rediscovered: the new biology and targeting the androgen receptor therapeuticallyCharles J Ryan, Donald J Tindall
Current Drug Targets|March 20, 2003
TGF-betal/Smad signaling in prostate cancerDiana Bello-DeOcampo, Donald J Tindall
Endocrine-Related Cancer|July 23, 2011
Alternatively spliced androgen receptor variantsScott M Dehm, Donald J Tindall
Journal of Carcinogenesis|September 3, 2011
Androgen receptor signaling in prostate cancer development and progressionPeter E Lonergan, Donald J Tindall
Nature Reviews. Urology|June 2, 2011
Targeting 5α-reductase for prostate cancer prevention and treatmentLucas P Nacusi, Donald J Tindall
Cancer Letters|October 3, 2002
The role of androgens and the androgen receptor in prostate cancerJose D Debes, Donald J Tindall
Cancer Cell|April 7, 2009
Unraveling the complexities of androgen receptor signaling in prostate cancer cellsHannelore V Heemers, Donald J Tindall
Pageof 11

Showing results (11-20 of 102) with videos related to

Sort By:
Pageof 11
The Journal of Biological Chemistry|July 28, 2006
Ligand-independent androgen receptor activity is activation function-2-independent and resistant to antiandrogens in androgen refractory prostate cancer cellsScott M Dehm, Donald J Tindall
Expert Review of Endocrinology & Metabolism|March 16, 2010
Androgen receptor abnormalities in castration-recurrent prostate cancerLucas P Nacusi, Donald J Tindall
Endocrine Reviews|October 18, 2007
Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complexHannelore V Heemers, Donald J Tindall
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2011
Androgen receptor rediscovered: the new biology and targeting the androgen receptor therapeuticallyCharles J Ryan, Donald J Tindall
Current Drug Targets|March 20, 2003
TGF-betal/Smad signaling in prostate cancerDiana Bello-DeOcampo, Donald J Tindall
Endocrine-Related Cancer|July 23, 2011
Alternatively spliced androgen receptor variantsScott M Dehm, Donald J Tindall
Journal of Carcinogenesis|September 3, 2011
Androgen receptor signaling in prostate cancer development and progressionPeter E Lonergan, Donald J Tindall
Nature Reviews. Urology|June 2, 2011
Targeting 5α-reductase for prostate cancer prevention and treatmentLucas P Nacusi, Donald J Tindall
Cancer Letters|October 3, 2002
The role of androgens and the androgen receptor in prostate cancerJose D Debes, Donald J Tindall
Cancer Cell|April 7, 2009
Unraveling the complexities of androgen receptor signaling in prostate cancer cellsHannelore V Heemers, Donald J Tindall
Pageof 11